Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01733173 · ClinicalTrials.gov registry record
Functional Imaging of Cerebellar Mutism Syndrome
A clinical trial of Brain Mass, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 4
- Enrollment target
- 1
- Study location
NCT01733173 is a study of Brain Mass that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 4 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01733173, a study of Brain Mass, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to better understand why some children with cancer have difficulty speaking after brain surgery. Difficulty speaking may be due to known complications to the language centers in the brain. These language centers may be located in slightly different places in different people. This study will study which areas may be damaged.
Conditions Studied
Interventions
- PROCEDURE MRI with DTI and fMRI
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-11 |
| Est. Completion | 2021-10-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01733173
The ClinicalTrials.gov registry entry for NCT01733173 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Mass appearing as the primary indexed condition, and to 1 intervention - of which MRI with DTI and fMRI is the first listed.
NCT01733173 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01733173 about?
NCT01733173 is a clinical study titled "Functional Imaging of Cerebellar Mutism Syndrome". The purpose of this study is to better understand why some children with cancer have difficulty speaking after brain surgery. Difficulty speaking may be due to known complications to the language centers in the brain. These language centers may be located in slightly different places in different pe...
What is the current status of trial NCT01733173?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2012-11. Estimated completion is 2021-10-12.
What conditions does trial NCT01733173 study?
This clinical trial studies the following conditions: Brain Mass.
What interventions are being tested in trial NCT01733173?
The interventions under investigation include: MRI with DTI and fMRI (PROCEDURE).
Who is sponsoring clinical trial NCT01733173?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01733173 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Mass
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.